Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

A pharma giant is moving past one patent cliff — but another is already looming

Disappointing data highlights Novartis' challenge to build its next generation of blockbuster medicines, following a series of clinical trial setbacks.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at cnbc.com →

More in Health & Medicine

More from Friday 30 October →